Immunotherapy and I

This resource helps people with colorectal cancer understand whether immunotherapy may be an option for them. It explains key eligibility factors such as biomarker results (MSI-H or dMMR), cancer stage, previous treatments, overall health, and provincial drug coverage.

It also outlines common sided effects, what to expect during treatment appointments, and key questions to ask your healthcare team. In addition, it provides guidance on accessing clinical trials and support resources to help guide your next steps.